APA

Nguyen Q. D., Shah S. M., Khwaja A. A., Channa R., Hatef E., Do D. V., Boyer D., Heier J. S., Abraham P., Thach A. B., Lit E. S., Foster B. S., Kruger E., Dugel P., Chang T., Das A., Ciulla T. A., Pollack J. S., Lim J. I., Eliott D., Eliot D. & Campochiaro P. A. (20101103). Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. : Ophthalmology.

Chicago

Nguyen Quan Dong, Shah Syed Mahmood, Khwaja Afsheen A, Channa Roomasa, Hatef Elham, Do Diana V, Boyer David, Heier Jeffery S, Abraham Prema, Thach Allen B, Lit Eugene S, Foster Bradley S, Kruger Erik, Dugel Pravin, Chang Thomas, Das Arup, Ciulla Thomas A, Pollack John S, Lim Jennifer I, Eliott Dean, Eliot Dean and Campochiaro Peter A. 20101103. Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. : Ophthalmology.

Harvard

Nguyen Q. D., Shah S. M., Khwaja A. A., Channa R., Hatef E., Do D. V., Boyer D., Heier J. S., Abraham P., Thach A. B., Lit E. S., Foster B. S., Kruger E., Dugel P., Chang T., Das A., Ciulla T. A., Pollack J. S., Lim J. I., Eliott D., Eliot D. and Campochiaro P. A. (20101103). Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. : Ophthalmology.

MLA

Nguyen Quan Dong, Shah Syed Mahmood, Khwaja Afsheen A, Channa Roomasa, Hatef Elham, Do Diana V, Boyer David, Heier Jeffery S, Abraham Prema, Thach Allen B, Lit Eugene S, Foster Bradley S, Kruger Erik, Dugel Pravin, Chang Thomas, Das Arup, Ciulla Thomas A, Pollack John S, Lim Jennifer I, Eliott Dean, Eliot Dean and Campochiaro Peter A. Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. : Ophthalmology. 20101103.